Picornaviruses are a large family of small, hardy viruses responsible for an enormous range of human illness, from the common cold to paralytic polio to liver inflammation. The name itself is a clue: “pico” (small) plus “RNA” (the type of genetic material they carry). Despite their tiny size, picornaviruses collectively cause more infections in humans each year than almost any other viral family, and several members have shaped public health history in profound ways.
What Makes a Picornavirus a Picornavirus
All picornaviruses share a handful of defining features. They are very small, roughly 22 to 30 nanometers across, and carry a single strand of RNA as their genetic blueprint. Unlike flu viruses or coronaviruses, picornaviruses lack a lipid envelope, the fatty outer coat that many viruses rely on. That missing envelope is a big deal: it makes picornaviruses tougher to kill with soap and common disinfectants, because those agents work largely by dissolving lipid membranes. Non-enveloped viruses can persist on surfaces and resist environmental conditions that would destroy many other pathogens.1PubMed Central. Suitable Disinfectants with Proven Efficacy for Genetically Modified Viruses and Viral Vectors
Inside the tiny protein shell, the RNA genome ranges from about 7,200 to 8,900 nucleotides in length. Once this RNA gets into a host cell, it can be read directly by the cell’s machinery, producing one large protein that gets sliced into smaller functional pieces by the virus’s own enzymes.2PubMed Central. Viruses with Single-Stranded, Positive-Sense RNA Genomes The virus also hijacks the cell’s internal membranes, reshaping them into specialized structures where new viral RNA gets copied and new virus particles are assembled.3PubMed Central. Dynamic lipid landscape of picornavirus replication organelles
The family is enormous. It currently contains more than 30 genera and hundreds of recognized species. The ones that matter most for human health fall into a few key groups: enteroviruses (which include poliovirus, coxsackieviruses, echoviruses, rhinoviruses, and enterovirus D68 and A71), hepatoviruses (hepatitis A), and parechoviruses. Each of these causes a distinct set of problems, which is why a single family can be behind both a runny nose and permanent paralysis.
How Picornaviruses Spread
The route of transmission depends on which picornavirus you’re dealing with, but there are two main patterns. Respiratory picornaviruses, especially rhinoviruses, travel through airborne droplets and direct contact. You catch a cold by breathing in virus-laden particles or by touching a contaminated surface and then touching your nose or eyes. Enteric picornaviruses, including poliovirus and hepatitis A, spread through the fecal-oral route: contaminated water, contaminated food, or close contact with an infected person who hasn’t washed their hands thoroughly.4Innovation in Science and Technology. Hepatitis A Virus (HAV) Infection: A Prevention Strategy Through Hygienic Maintenance and Vaccination
The environmental toughness of picornaviruses is what keeps them circulating so effectively. Without a lipid envelope, they can survive on doorknobs, toys, and countertops for hours to days depending on conditions. Alcohol-based hand sanitizers are less effective against non-enveloped viruses than against enveloped ones, so thorough handwashing with soap and water remains the single best defense for the enteric members of the family. For surface disinfection, products with proven activity against non-enveloped viruses are necessary.
Rhinoviruses and the Common Cold
Rhinoviruses are the most common picornaviruses you’ll encounter and the leading cause of the common cold. With well over 100 recognized types, they infect people year-round, though infections peak in fall and spring in temperate climates. Most rhinovirus colds are mild and self-limiting: a few days of congestion, sore throat, sneezing, and perhaps a low-grade fever.
The real clinical concern with rhinoviruses is what they do to people with pre-existing airway disease. Rhinovirus is the primary pathogen triggering acute flare-ups of asthma and chronic obstructive pulmonary disease.5PubMed Central. Broad-spectrum host-targeting antivirals for rhinovirus infections: mechanisms and future perspectives In children with asthma, a rhinovirus cold can quickly escalate into wheezing, shortness of breath, and emergency department visits. There is no vaccine for rhinovirus, largely because the sheer number of types makes a single vaccine impractical, and no antiviral is approved for treatment. Management remains supportive: rest, fluids, and over-the-counter symptom relief.
Enteroviruses and the Diseases They Cause
Enteroviruses are the largest and most medically diverse group within the picornavirus family. Most enterovirus infections are either asymptomatic or produce a mild febrile illness that resolves on its own. But certain enteroviruses can invade the central nervous system or other organs, causing serious and sometimes fatal disease. A few of the most important members deserve individual attention.
Poliovirus
Poliovirus is the most historically significant picornavirus. In its most severe form, it reaches the central nervous system and replicates in motor neurons, destroying them and causing the irreversible paralysis known as paralytic poliomyelitis.6PubMed Central. Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway Most poliovirus infections, however, produce no symptoms at all or only a brief flu-like illness. The paralytic form occurs in a small fraction of those infected, but given how widely the virus once circulated, that fraction translated into tens of thousands of cases of childhood paralysis each year before vaccines became available.
Coxsackieviruses and Hand, Foot, and Mouth Disease
Hand, foot, and mouth disease is one of the most recognizable childhood illnesses, and it is caused by enteroviruses, most commonly coxsackievirus A16 and enterovirus A71.7PubMed Central. Whole-genome sequencing and phylogenetic analysis of coxsackievirus-A16 strains causing hand, foot and mouth disease (HFMD) in India The classic presentation is small blisters on the palms, soles, and inside the mouth, along with fever. It spreads readily in daycare and preschool settings and usually resolves within a week.
Some strains produce atypical presentations that can alarm parents and clinicians alike. Coxsackievirus A6, for instance, has been associated with widespread, purpuric (bruise-like) patches on the hands and feet, as well as blistering rashes extending to the trunk, limbs, and face, which can look much more severe than the textbook version of hand, foot, and mouth disease.8PubMed. Coxsackievirus A6-Induced Atypical Hand-Foot-Mouth Disease Even these cases typically resolve without specific treatment, though the appearance can be alarming enough to prompt urgent medical evaluation.
Enterovirus A71
Enterovirus A71 also causes hand, foot, and mouth disease, but it carries a higher risk of neurological complications than most other enteroviruses. In large outbreaks, particularly in East and Southeast Asia, EV-A71 has been responsible for brainstem encephalitis, aseptic meningitis, and acute flaccid paralysis in young children.9PubMed Central. Enterovirus 71 infection and neurological complications Among those complications, brainstem encephalitis is the most dangerous because it can lead to catastrophic pulmonary hemorrhage or edema and death.10PubMed Central. Cardiopulmonary failure in children infected with Enterovirus A71 China has licensed an EV-A71 vaccine, but it is not widely available outside that country.
Enterovirus D68
Enterovirus D68 behaves somewhat unusually for an enterovirus: it spreads primarily through the respiratory route, like a rhinovirus, rather than through the fecal-oral route. It causes respiratory illness ranging from a common cold to severe wheezing and pneumonia. What brought EV-D68 to global attention was a series of outbreaks in 2014 and 2016 that coincided geographically and temporally with clusters of acute flaccid myelitis, a condition in which lesions in the spinal cord cause sudden limb weakness or paralysis in children.11PubMed Central. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality
Establishing a definitive causal link took years, partly because the virus was rarely found in cerebrospinal fluid and could not initially be isolated from affected nerve tissue. Applying established epidemiological criteria, however, researchers found that the evidence supported a causal relationship, particularly for a specific genetic lineage (clade B1) that proved capable of causing nerve damage in animal models.12PubMed Central. The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) – what is the evidence for causation? There is currently no vaccine or approved antiviral for EV-D68.
Hepatitis A
Hepatitis A virus is a picornavirus that targets the liver rather than the respiratory tract or nervous system. Infection spreads through contaminated food or water, or through close contact with an infected person. The illness typically presents with fatigue, nausea, abdominal pain, and jaundice (yellowing of the skin and eyes). In children, hepatitis A is often mild or even asymptomatic, but in adults it can mean weeks of debilitating illness. Unlike hepatitis B and C, hepatitis A does not cause chronic infection; the liver recovers fully in the vast majority of cases.4Innovation in Science and Technology. Hepatitis A Virus (HAV) Infection: A Prevention Strategy Through Hygienic Maintenance and Vaccination
Hepatitis A is one of the picornavirus success stories in terms of prevention. Highly effective inactivated vaccines have been available for decades, and immunization after a standard course produces seroconversion rates above 98%.13PubMed Central. The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy In countries with routine childhood hepatitis A vaccination, case numbers have plummeted. In lower-income settings where vaccine coverage is low and sanitation is inconsistent, hepatitis A remains common.
Parechoviruses and Illness in Newborns
Human parechoviruses are less well known than the enteroviruses but deserve attention, especially from parents of very young infants. Parechovirus genotype 3, in particular, can cause severe illness in neonates and young infants, including a sepsis-like syndrome with high fever, irritability, and poor feeding, as well as central nervous system infections.14PubMed. Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, Austria Older children and adults who catch the same virus usually have mild or no symptoms, making it easy to unknowingly pass the virus to a vulnerable infant. There is no vaccine or specific treatment; care is supportive, and awareness among pediatricians has been increasing in recent years.
How Picornavirus Infections Are Diagnosed
Most mild picornavirus infections, like the average rhinovirus cold, go undiagnosed because testing is unnecessary. When clinicians do need to identify the specific virus, the standard modern approach is reverse-transcription polymerase chain reaction (RT-PCR), a technique that detects viral RNA in respiratory secretions, stool, cerebrospinal fluid, or blood. RT-PCR is far more sensitive than the older method of growing viruses in cell culture and has made it possible to identify picornaviruses in clinical settings that previously went unrecognized.15PubMed Central. Molecular detection and typing of human picornaviruses
One wrinkle with highly sensitive molecular tests is that they sometimes detect picornavirus RNA in people who aren’t actually sick. In studies that tested healthy children on a regular schedule, rhinovirus was frequently detected even in the absence of symptoms.16PubMed. Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season This means a positive test doesn’t automatically explain a child’s illness; clinicians have to consider the clinical picture alongside the lab result.
Vaccines That Exist and Vaccines That Don’t
The picornavirus family includes some of the greatest vaccine success stories in history, alongside some conspicuous gaps. Poliovirus vaccines (both the injectable inactivated version and the oral live-attenuated version) have reduced global polio cases by over 99% since mass vaccination began. Hepatitis A vaccines are safe, highly immunogenic, and widely available. And China has licensed an EV-A71 vaccine for children.
Beyond these, though, the cupboard is largely bare. There is no vaccine for rhinoviruses, coxsackieviruses (aside from EV-A71), enterovirus D68, or parechoviruses. Part of the problem is antigenic diversity: rhinoviruses alone have more than 100 types, and immunity to one provides little protection against another. For enteroviruses like EV-D68, the relative rarity of severe complications makes it harder to justify the cost and scale of vaccine development, even though individual outbreaks can be devastating. Researchers are actively working on broader approaches, but nothing is close to licensure for these targets.
The Unfinished Fight Against Polio
Wild poliovirus type 1 remains endemic in parts of Pakistan and Afghanistan, and the global eradication effort that began in 1988 has entered a frustrating endgame. One complication has been the emergence of circulating vaccine-derived poliovirus type 2 (cVDPV2). The oral polio vaccine uses weakened live virus, and in populations with low immunization coverage, the vaccine strain can mutate as it passes from person to person, eventually regaining the ability to cause paralysis.17PubMed Central. Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges
Over the past decade, cVDPV2 has become the dominant cause of polio cases globally. Between 2017 and 2026, it accounted for roughly 86% of all reported polio cases, spread across 57 countries.18PubMed. WPV1 resurgence and the dominant threat of cVDPV2: a 10-year global epidemiological analysis (2017-2026) To address this, a novel oral polio vaccine type 2 (nOPV2) has been developed with additional genetic safeguards to reduce the risk of reversion. Deploying it effectively alongside the existing bivalent oral vaccine remains one of the central logistical challenges of the eradication program.19PubMed Central. Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame
Why Antiviral Drugs Are So Scarce
For most picornavirus infections, treatment is entirely supportive: fluids, rest, fever management. There are no approved broad-spectrum antivirals for the family as a whole, and even virus-specific drugs are virtually nonexistent in clinical use. This is not for lack of trying. Pleconaril, a drug that blocks the uncoating step of several enteroviruses and rhinoviruses, showed promise in trials but was never approved for general use due to concerns about drug interactions and modest efficacy in mild illness.
Research is ongoing. Some experimental compounds from kinase inhibitor libraries have been shown to block replication of poliovirus, coxsackievirus B3, and other picornaviruses in the lab by interfering with the processing of the viral polyprotein.20PubMed Central. New small-molecule inhibitors effectively blocking picornavirus replication A newer and more creative approach targets the 3C protease, an enzyme every picornavirus needs to slice its polyprotein into functional parts. Researchers have designed molecules that not only block this enzyme but also tag it for destruction by the cell’s own waste-disposal system. In lab experiments, this strategy inhibited enterovirus 71 replication through a two-pronged attack and showed activity against the 3C protease from multiple different picornaviruses, suggesting potential for broad-spectrum use.21PubMed Central. Targeted Degradation of Picornaviral 3C Protease via PROTACs Confers High Barrier to Viral Resistance and Broad‐Spectrum Antiviral Activity Both approaches are still in preclinical stages, but they represent a shift from targeting individual viruses to exploiting shared vulnerabilities across the family.
Picornaviruses Evolve Fast
One reason picornaviruses are so hard to control with drugs or vaccines is that they mutate rapidly. Their RNA-dependent RNA polymerase, the enzyme that copies their genome, lacks a proofreading function, so copying errors accumulate at a high rate. Among all viruses, picornaviruses have some of the highest nucleotide substitution rates, and enteroviruses in particular evolve roughly half an order of magnitude faster than other picornavirus genera.22PubMed Central. Genus-specific substitution rate variability among picornaviruses This rapid evolution fuels the emergence of new strains, complicates vaccine design, and is the fundamental reason why oral polio vaccine strains can revert to a virulent form in under-immunized communities.
Wastewater Surveillance as an Early Warning System
COVID-19 brought wastewater surveillance into the mainstream, but the same technique is proving valuable for tracking picornaviruses. Environmental surveillance of sewage has been used for decades to monitor poliovirus circulation, and more recently it has been extended to other enteroviruses. In a 2024 study in Niigata City, Japan, researchers tested wastewater samples weekly and detected enterovirus D68 RNA about five weeks before hospitalizations for wheezing in children began to climb. The concentration of viral RNA in wastewater correlated with pediatric hospital admissions, and the surveillance also revealed genetic subclades circulating in the community that were never identified in clinical samples from patients.23PubMed Central. Prospective use of wastewater surveillance for early detection of enterovirus D68 in community outbreaks among children, Niigata City, Japan, 2024
The practical implication is significant. If public health authorities can see a surge in EV-D68 in the sewage weeks before children start showing up in emergency departments with breathing difficulties, they can alert clinicians, prepare hospital capacity, and target preventive messaging to parents. The same framework could extend to other picornaviruses and other respiratory pathogens.24PubMed Central. Successful Early Detection of the Enterovirus-D68 Outbreak among Children by Wastewater Surveillance in Niigata City, Japan, 2024
Picornaviruses in Animals
The picornavirus family does not limit itself to humans. The single most economically devastating picornavirus worldwide is foot-and-mouth disease virus (FMDV), which infects cattle, pigs, sheep, and other cloven-hoofed animals. It does not make people seriously ill, but outbreaks in livestock herds trigger mass culling, trade bans, and billions of dollars in losses. FMDV is extraordinarily contagious among animals: in unvaccinated pig herds, a single infected animal can be expected to infect roughly 39 others on average.25PubMed Central. The pathogenesis of foot-and-mouth disease virus: current understandings and knowledge gaps Even in vaccinated groups, the virus still spreads, though at a much lower rate. Countries that are currently free of foot-and-mouth disease maintain strict import controls on livestock and animal products to keep it out, which is why you’ll sometimes see border agents confiscating a salami sandwich at the airport. The virus itself is yet another non-enveloped picornavirus, sharing the same tough, persistent characteristics that make its human relatives so hard to eliminate from the environment.